Journey Medical Corp (DERM)
3.45
-0.17
(-4.70%)
USD |
NASDAQ |
May 17, 16:00
3.45
0.00 (0.00%)
Pre-Market: 20:00
Journey Medical Cash from Operations (TTM): 1.177M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.177M |
December 31, 2023 | 5.24M |
September 30, 2023 | 17.92M |
June 30, 2023 | -8.105M |
March 31, 2023 | -15.37M |
Date | Value |
---|---|
December 31, 2022 | -13.53M |
September 30, 2022 | -12.90M |
June 30, 2022 | 1.48M |
March 31, 2022 | -2.658M |
December 31, 2021 | -2.181M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-15.37M
Minimum
Mar 2023
17.92M
Maximum
Sep 2023
-2.894M
Average
-2.420M
Median
Cash from Operations (TTM) Benchmarks
Fortress Biotech Inc | -110.39M |
Stereotaxis Inc | -8.683M |
GT Biopharma Inc | -8.852M |
Cara Therapeutics Inc | -87.91M |
FibroGen Inc | -272.72M |